CFTR and cystic fibrosis: In conclusion, our data provide a strong basis for the improvement of CFTR genetic diagnostics in classical forms of CF by achieving an almost 100% population-based mutation detection rate, the eventual introduction of CF neonatal screening in the country using e.g. an IRT-DNA strategy and provides a basis for the introduction of other forms of targeted therapies beyond CFTRm in indicated cases.